23andMe Lays Off 40% of Its Workforce as Company Spirals
The genetic testing company 23andMe announced it was laying off more than 200 employees, or roughly 40% of its entire workforce, according to a press release Monday. The move is part of a restructuring that will see the company also halt the development of its therapeutics division which had been working on various potential medical treatments.
In the wake of a big data breach and a sizable new round of layoffs, concerns about the 23andMe's handling of sensitive ...
Genetics testing company 23andMe is trimming its headcount by 40%. The company said it is undergoing a restructuring to ...
Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...
DNA-testing service 23andMe is making substantial efforts to nurse its feeble genetic core back to health. The company will ...
NEW YORK — 23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics ...
23andMe is laying off 40 percent of its employees, or over 200 workers, as the company attempts to recover from last year’s ...
Millions of people have sent their DNA to be analyzed by 23andMe in order to learn their genealogy and risk for certain ...
Embattled genetic testing provider 23andMe said on Tuesday that revenue declined from a year earlier, a day after the company ...
23andMe on Tuesday reported that second-quarter revenue fell to $44.1 million from $50 million a year earlier. The ...
Me announced on Monday it would cut 40% of its workforce, representing more than 200 employees, as part of a restructuring at ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback